CONTENT
Clinical trials open to people with HIV in Luxembourg
| Trial | Phase | Patients | Recruitment |
|---|---|---|---|
| MK-0518 | Early Access Program | multiresistant | CLOSED |
| TMC125 | compassionate use | multiresistant | OPEN |
| TMC114 | compassionate use | multiresistant | CLOSED |
| Tipranavir (BI 1182.16) | compassionate use | multiresistant | CLOSED |
| Klean | IIIb | naive | CLOSED |
| SMART | other | CLOSED | |
| COLATE | CLOSED | ||
| Stratum A | Phase IIIa | a)first failures | |
| Stratum B (CHIP) | Phase | b)subsequent failures | |
| T20 (Roche) | Phase II | multiresistant | CLOSED |
| TMC114-C207 (Tibotec) | Phase II | failures | CLOSED |
| RENOIR (Roche) | Phase IV | non-treated | CLOSED |
| Initio (ANRS – MRC) | Phase IV | non-treated | CLOSED |
| Viradapt II / Pharmadapt | Phase IV | all failures | CLOSED |
| Atazanavir (BMS) | Phase IIIB | multiresistant | CLOSED |
| Atazanavir-SWAN (BMS) | Phase IIIB | multiresistant | CLOSED |
| Tipranavir (BI 1182.51) | Phase II | failures | CLOSED |
| Tipranavir (BI 1182.17) | Phase II/III | rollover | CLOSED |
| Tipranavir (BI 1182.48) | Phase III | multiresistant | CLOSED |
| Atazanavir | compassionate use | CLOSED |
For more information, contact Valérie Etienne
phone: +352-26970-217
fax: +352-26970-221
